Trials / Completed
CompletedNCT01768507
Reresveratrol Administered to Healthy Male Subjects
The Effects of the Dietary Supplement Trans-resveratrol on Heme Oxygenase-1 (HO-1) and Sirtuins Expression in PBMCs in Healthy Male Subjects: A Pilot Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Daniel Doberer · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Heme oxygenase 1 (HO-1) serves as a protective gene. The aim of this clinical trial is to evaluate the HO-1 stimulation of resveratrol in healthy humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Resveratrol | 5 g (10 capsules) as single oral dose on day 1 |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2013-01-15
- Last updated
- 2016-09-15
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01768507. Inclusion in this directory is not an endorsement.